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BDNF influences neuronal differentiation in development, as well as synaptic plasticity and neuronal survival in adulthood (Thoenen, 1995). Several results suggest
that it may play a role in the pathophysiology of depression (Duman, 2002). Heterozygous BDNF knockout mice
show behavioral abnormalities consistent with serotonergic dysfunction. These behavioral changes are corrected
through antidepressant treatment (Lyons et al, 1999). Additional evidence connecting BDNF and depression comes
from studies showing that infusion of recombinant BDNF
into the mouse midbrain (Siuciak et al, 1997) or hippocampus (Duman, 2002) produces an antidepressant effect in
both learned helplessness and forced swim models of depression. Furthermore, stress, a trigger for depression, lowers hippocampal transcription of BDNF in mice (Nibuya
et al, 1995). In contrast, numerous antidepressants, including selective serotonin reuptake inhibitors, electroconvulsive therapy, lithium, and monoamine oxidase inhibitors
(Nibuya et al, 1995; Russo-Neustadt et al, 1999), increase
BDNF transcription. This transcriptional increase occurs after a delay similar to that seen in the onset of clinical effects
of antidepressants (Nibuya et al, 1995).
The recent finding that there is significant neurogenesis
in the hippocampi of adult primates suggests a mechanism
through which BDNF might relate to depression (Gould et
al, 1999). The hippocampi of depressed patients are significantly smaller than those of healthy individuals (Sheline,
2000). This reduced volume may be the result of decreased
neurogenesis in depressed individuals, a possibility sup-

Introduction
Genetic factors influence vulnerability to depression
(Sullivan et al, 2000), but no specific genes have been definitively implicated. One promising approach is to determine whether variations in specific (candidate) genes are
associated not with disease per se, but with traits, such as
personality factors, that are themselves associated with
risk for the disorder (Lander and Schork, 1994; Stoltenberg and Burmeister, 2000). Often such traits have a higher
heritability than the disease status (Almasy and Blangero,
2001). Neuroticism, as measured by the NEO personality
inventory (NEO-PI) (Costa and McCrae, 1997), a psychometrically sound and widely used instrument, is one such
trait. High scorers on the Neuroticism domain are characterized by frequent experience of “negative emotionality” such as anxiety, low mood, and hostility. Converging
lines of evidence point to brain-derived neurotrophic factor (BDNF) as a factor in the pathophysiology of depression. To explore the possibility that variation in the BDNF
gene is, in part, responsible for the population variation in
Neuroticism, we studied a community sample of 441 subjects, genotyping a G→A single-nucleotide polymorphism
(SNP) responsible for a valine→methionine substitution in
the prodomain of BDNF. The less common, nonconserved
Met allele was associated with significantly lower mean
Neuroticism scores (p = 0.0057). Our study provides further evidence and one possible mechanism linking BDNF
to depression.
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ported by the findings that hippocampal neurogenesis is
reduced by stress (Gould et al, 1998) and increased by antidepressant treatment (Malberg et al, 2000). The parallel
changes in BDNF levels and neurogenesis in response to
stress and antidepressant treatment suggest a connection
between BDNF and hippocampal neurogenesis. Together,
these lines of evidence lead to the neurotrophic hypothesis
of depression (Duman et al, 1997), suggesting that genetic
variations in BDNF might influence hippocampal neurogenesis and ultimately vulnerability to depression.
Neuroticism is a strong marker for vulnerability to depression (Duggan et al, 1995; Kendler et al, 1993). Characteristics of Neuroticism make it particularly useful for genetic
studies of depression. The reported heritability of Neuroticism is 40–50% (Jang et al, 1996; Lake et al, 2000), equal to
or greater than heritibility estimates for depression (36%)
(Kendler and Prescott, 1999). Furthermore, approximately
70% of the correlation between Neuroticism and depression risk is because of shared genetic risk factors (Kendler
et al, 1993). Neuroticism is also a quantitative trait and stable through adulthood (Costa and McCrae, 1988). In this
study, we explore whether a BDNF variant is associated
with variation in Neuroticism.
Methods
Subjects
The subjects, 268 female and 173 male, were from 257
families participating in the Family Blood Pressure Program at the Tecumseh, Michigan Site (Boerwinkle, 2002).
In all, 99% of the subjects were non-Hispanic Caucasians.
Family eligibility in this study was dependent on the availability of a proband between 25 and 40 years old with a
systolic blood pressure in the upper 15% of blood pressure
distribution in earlier rounds of examination. Parents and
siblings of probands were studied when available.
Genotyping
In Genbank sequences and the public SNP database (
http://www.ncbi.nlm.nih.gov/ ), we identified a common
coding variant in the BDNF gene, a G→A polymorphism
responsible for a Val66Met change (Cargill et al, 1999). Electronic restriction mapping showed that the “A” allele creates a restriction site for the enzyme Hsp92II. We designed
primers (SBDNF1-AAA GAA GCA AAC ATC CGA GGA
CAA G; SBDNF2-ATT CCT CCA GCA GAA AGA GAA
GAG G) resulting in a 274 bp PCR product. A PTC 100
thermal cycler (MJ Research, Watertown, MA, USA) was
used for DNA amplification. Amplification reactions were
performed in a total volume of 20 μl, containing approximately 50 ng of genomic template, 1 μM of each primer,
200 μM dNTP, 2 μl 10X Opti-Prime Buffer 6 (Stratagene,
La Jolla, CA, USA) and 1 U of Taq polymerase. The PCR
cycling conditions consisted of an initial denaturation for
2 min at 94°C followed by 35 cycles of 94°C for 1 min, 55°C
for 2 min, and 72 for 2 min and a final extension at 72°C for
4 min. In the presence of the “G” allele, Hsp92II digestion
produced two products, 57 and 217 bp, whereas the “A” allele produced 3 products, 57, 77, and 140 bp. The presence
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of a second Hsp92II site served as a restriction digest control, identifying incomplete digests for repeat analysis. PCR
products were electrophoresed on a 2% agarose gel and visualized using the Gel-Star nucleic acid gel stain (BioWhittaker Molecular Applications, Rockland, ME, USA). Of all
subjects, 91% were successfully genotyped.
Personality Inventory
The NEO-PI was administered to the subjects in the
study. This inventory, consisting of 181 questions, assesses subjects on five global personality domains and
breaks down three of these domains into six specific facets
each. The NEO-PI is a well-established inventory designed
through factor analytic strategies. The inventory provides
high test–retest reliability and longitudinal stability (Costa
and McCrae, 1997).
Statistical Analysis
The presence of association was determined using the
QTDT Program version 2.1 (available at http://www.sph.
umich.edu/statgen/abecasis/QTDT/ ). QTDT was used to
fit a variance components model to account for familial resemblance because of kinship and linkage. However, rather
than modeling allelic effects based on allelic transmission,
we tested the overall additive genetic effect of each polymorphism (Abecasis et al, 2000a, 2000b).
Results
We analyzed DNA samples from 441 subjects in the
Tecumseh, Michigan Blood Pressure Study (Boerwinkle,
2002) at a G→A polymorphism responsible for a Val66Met
change (Cargill et al, 1999) in the prodomain of the BDNF
gene. The frequency of the alleles (adjusted for familial correlations) were: Val = 0.75, Met = 0.25, similar to previously
reported frequencies (Val = 0.68 and 0.83, Met = 0.32 and
0.17) (Cargill et al, 1999; Sklar, in press). In this sample there
was no significant correlation between blood pressure and
Neuroticism (diastolic blood pressure r = –0.064, p = 0.116;
systolic blood pressure r = -0.016, p = 0.696). Since the mean
Neuroticism score for the heterozygous Val/Met group was
intermediate to the two homozygous groups, an additive
model of genotype effect was used. In an analysis controlling for familial correlations, the Met allele showed a significant association with lower mean Neuroticism scores (p =
0.0057; Figure 1). No personality domain, other than Neuroticism, was associated with BDNF genotype (Table 1). Of
the six Neuroticism facets, only depression (N3), self-consciousness (N4), anxiety (N1), and vulnerability (N6) were
associated with BDNF genotype. Of the 12 facets comprising the other personality domains, only the openness facet,
feelings (O3) was associated with BDNF genotype (Table
2). This association was modest. For all but one of the associated facets, the heterozygous Val/Met group score was
intermediate to the two homozygous groups, supporting
an additive model for genotype effect. For the O3 facet, the
heterozygous Val/Met group score was similar to the Met/
Met group score, supporting a model where the Met allele
may have a dominant effect.
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Table 2. NEO-PI facet scoresa as a function of BDNF genotype in
Tecumseh population
Facet

Figure 1. NEO-PI neuroticism scores as a function of BDNF genotype.
Table 1. NEO-PI domain scores as a function of BDNF genotype
Domain

BDNF genotype

N

Mean

SEM

p value

Neuroticism
Val/Val
255
86.35
1.27
0.0057
 	
Val/Met
161
83.11
1.67	 
 	
Met/Met
20
73.90
3.66	 
 	 	 	 	 	 
Extraversion
Val/Val
255
107.22
1.07
0.329
 	
Val/Met
162
108.17
1.40	 
 	
Met/Met
20
111.18
2.76	 
 	 	 	 	 	 
Openness
Val/Val
254
104.19
1.07
0.197
 	
Val/Met
160
101.90
1.23	 
 	
Met/Met
20
102.18
3.69	 
 	 	 	 	 	 
Conscientiousness Val/Val
258
48.10
0.50
0.736
 	
Val/Met
161
47.53
0.66	 
 	
Met/Met
20
48.53
1.95	 
 	 	 	 	 	 
Agreeableness
Val/Val
259
47.19
0.40
0.721
 	
Val/Met
162
47.21
0.55	 
 	
Met/Met
20
48.05
1.94	 

A concern for this type of study is the potential presence of population stratification resulting in the appearance of false associations (Lander and Schork, 1994). To
assess if the reported results were because of stratification, STRUCTURE, a program designed to infer population structure utilizing genotypes from numerous unlinked markers as genomic controls, was implemented
(Pritchard and Rosenberg, 1999). Weak evidence for clustering into two groups was found (p = 0.02) (Theil and
Schork, personal communication; data available upon
request). There were no significant differences in either
BDNF allele frequency or any of the personality traits between the two clusters. Furthermore, the population cluster that was nonsignificantly higher for mean Neuroticism
scores had a nonsignificantly greater Met allele frequency.
Thus, these reported results are unlikely to be the product of population stratification (data available on request).
An additional concern for this study is that the population sample studied was chosen through the presence of

BDNF genotype N

Mean

SEM

p value

N1—anxiety
Val/Val
258
15.83
0.31
0.0020
 	
Val/Met 161
14.94
0.38	 
 	
Met/Met
20
13.52
1.02	 
 	 	 	 	 	 
N2—hostility
Val/Val
258
12.18
0.28
0.597
 	
Val/Met 161
11.98
0.37	 
 	
Met/Met
20
11.77
0.82	 
 	 	 	 	 	 
N3—depression
Val/Val
255
14.39
0.34
0.0058
 	
Val/Met 161
13.34
0.46	 
 	
Met/Met
20
11.39
1.04	 
 	 	 	 	 	 
N4—self-consciousness Val/Val
258
15.74 15.74
0.0086
 	
Val/Met 161
14.86 14.86	 
 	
Met/Met
20
13.05 13.05	 
 	 	 	 	 	 
N5—impulsiveness
Val/Val
258
16.72
0.23
0.497
 	
Val/Met 161
16.91
0.31	 
 	
Met/Met
20
15.15
1.13	 
 	 	 	 	 	 
N6—vulnerability
Val/Val
259
11.41
0.23
0.0390
 	
Val/Met 162
11.08
0.34	 
 	
Met/Met
20
9.00
0.70	 
 	 	 	 	 	 
O3—feelings
Val/Val
254
20.90
0.24
0.0215
 	
Val/Met 161
19.78
0.28	 
 	
Met/Met
20
19.92
0.83	 
a

All six Neuroticism facets are shown along with O3, the only facet
from the other domains that reached nominal significance.

a moderately hypertensive proband. Although there is no
association in this sample between blood pressure and either BDNF or Neuroticism, the hypertensive nature of the
sample should be noted. Lastly, we have demonstrated a
role for this BDNF variant in personality variation in a rural Michigan, non-Hispanic Caucasian sample, but its role
in other populations is not known.
Discussion
Our results indicate that this BDNF polymorphism may
account for a small, but significant proportion of the population variation in Neuroticism. This variant explains about
4% of the genetic variance in our sample. There are several
reasons to think that these results for Neuroticism are relevant to depression. First, Neuroticism is strongly associated
with depression (Duggan et al, 1995; Kendler et al, 1993).
This established association between Neuroticism and depression is mediated entirely by four of the six Neuroticism
facets: anxiety (N1), depression (N3), self-consciousness
(N4), and vulnerability (N6) (Bagby et al, 1996). These four
facets are precisely those that associate with BDNF genotype in the Tecumseh sample. The other two Neuroticism
facets, hostility (N2) and impulsiveness (N5), are not associated with depression and show no association with BDNF
in this study ( Table 2). Outside of the Neuroticism domain,
the facets that have been associated with depression are
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aesthetics (O2) and feelings (O3) (Bagby et al, 1996; Wolfenstein and Trull, 1997). In our sample, the feelings (O3) facet
is significantly associated with BDNF while aesthetics (O2)
shows a trend towards an association (p < 0.10). The reported p values were not corrected for multiple testing.
However, when the BDNF association with Neuroticism is
corrected for the 5 NEO-PI domains, the results remain significant. This is conservative since we went into this study
with an a priori hypothesis that BDNF may be a candidate
gene for Neuroticism, not the other domains. Since the facets are strongly associated with each other, it is difficult to
assess how to correct for further multiple testing.
Further evidence that the Val allele might increase the
risk of depression comes from a study showing that this Val
allele was preferentially transmitted to bipolar probands in
families (Sklar, in press). The finding that the Val allele is associated with the risk of clinical bipolar disorder supports
our findings that the same allele is associated with increased
scores on personality facets associated with depression in a
community sample. While the effect size of this BDNF variant for Neuroticism is not large, the effect is in the same direction as in bipolar disorder and of the magnitude expected
for an intermediate phenotype in a polygenic trait.
The functional significance of this Val→Met substitution,
if any, is unknown. Protein sequence comparisons (data not
shown) reveal that the common Val allele is completely conserved among > 70 species including mammals, birds and
fish (Murphy et al, 2001). That is, the “protective” Met allele
appears to be novel in evolutionary history. Our results, together with the neurotrophic hypothesis of depression (Duman et al, 1997), predict that the Met allele of BDNF produces higher activity or more efficient processing of BDNF.
Given the proximity of this variant to a BDNF cleavage site,
it is possible that this variant affects the efficiency of cleavage at this site (Mowla et al, 2001). The variant may also be
involved in determining the efficiency of mature BDNF folding. Alternatively, the variant may have no functional consequence, but be in linkage disequilibrium with a nearby functional polymorphism. These models can be tested in vitro or
in animal models. Given the increase of BDNF transcription
in response to antidepressant treatment, further work is also
indicated to determine if this genetic variation predicts clinical response to specific antidepressants.
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